NovoTech Patent Firm Ranked in Inaugural Chambers 2027 DC Metro Spotlight Guide  PR Newswire

NovoTech Patent Firm has been recognized in the Chambers USA Spotlight 2027 DC Metro Guide for expertise in Intellectual Property, showcasing its impact in the legal field.

Novotech Aus BidCo Pty Ltd, a subsidiary of Novotech SG Holdings Pty Ltd (Novotech) proposes to acquire 100% of the shares in Agilex Biolabs Pty Ltd (Agilex).

Label: Iono Music Catalog: INM1DIGI1031 Released: 2026-10-16 Style: Psy-Trance Bitrate: Flac+320kbps Tracklist: 01. May the Flow Be with You (Novotech Remix) (8:14) [center] [center] send.cm - flac send.cm - 320...

ASX-listed pathology group Healius has completed the sale of its Agilex Biolabs division to Novotech, a $3 billion-plus clinical research organization controlled by global buyout firm TPG, and Singaporean investment giants GIC and Temasek. The transaction, valued at $150 million, involves Agilex Biolabs, which provides preclinical and clinical trial services to biotechnology and pharmaceutical companies. This sale marks a strategic move by Healius to focus on its core pathology services, divesting from its clinical research unit. Novotech, a major player in the clinical research sector, has expanded its portfolio through this acquisition, enhancing its capabilities in supporting drug development and clinical trials. The deal follows a period of active market interest, with sell-side adviser UBS issuing over 30 investment memorandums seeking non-binding offers before the end of July. The transaction was announced on September 24, 2026, by the Australian Financial Review, with Sarah Thompson, Kanika Sood, and Angira Bharadwaj as the authors. The sale reflects broader trends in the healthcare sector, where companies are increasingly streamlining operations to concentrate on core competencies and strategic growth areas. Healius, a leading pathology provider, aims to optimize its business model by shedding non-core assets, while Novotech strengthens its position in the competitive clinical research market. This acquisition is expected to bolster Novotech's capacity to deliver comprehensive clinical trial solutions to its clients in the biotech and pharmaceutical industries. The deal underscores the ongoing consolidation and strategic realignment within the healthcare and clinical research sectors, highlighting the importance of specialized services in supporting the development of new medical treatments and therapies.

Babak Akhlaghi, Founding Director of NovoTech Patent Firm, has been celebrated by top organizations for his contributions in intellectual property, marking the eighth consecutive year of accolades.

Apple's $634M patent loss reveals how USPTO changes are transforming tech innovation strategy from "challenge and invalidate" to "license first."

The firms are American Photonics, Novotech, Inc., Echodyne, Marvin Engeering Company, Inc., Exovera, Teledyne Brown Engineering, Inc., BRINC Drones, Inc., SYNEXXUS, Inc., Firestorm Labs, Inc., Kratos ...

Multi-trial agreement establishes a standardized digital foundation to support consistent, scalable execution across global studies

Multi-trial agreement establishes a standardized digital foundation to support consistent, scalable execution across global studies

Multi-trial agreement establishes a standardized digital foundation to support consistent, scalable execution across global studies

HONG KONG, May 19, 2025 - (PressReleaseCC) – CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom

In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent accomplishment of winning the Citeline CRO Partnership of the Year Award in recognition of its partnership with Tune Therapeutics. Ng-Cashin highlighted the importance of seamless, trusting relationships in clinical research, as well as the roles of cost efficiency, risk-based approaches, and leveraging CRO expertise to navigate partnerships in the evolving regulatory landscape.

Castellammare  – Nuovo passo avanti per il Seagull, l’innovativo idrovolante progettato da Novotech in collaborazione con il Dipartimento di Ingegneria Industriale dell’Università Federico II di Napoli. Questa mattina, nelle acque del Porto Commerciale di Castellammare di Stabia, il velivolo ha affrontato una delicata fase di prove di tenuta, tappa cruciale...

Novotech is a Dual Category Award Winner in the 2025 Clinical Trials Arena Excellence Awards